T-Cells For The Win With Adaptimmune's Adrian Rawcliffe
Business Of Biotech
The Future of T-Cell Therapies and Genericization Challenges
This chapter discusses the challenges and potential of T-cell therapies in comparison to traditional monoclonal antibodies, focusing on patenting and manufacturing issues. It highlights the promise of generics and biosimilars in the industry while forecasting advancements in regulatory frameworks for improved access to these biopharmaceuticals.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
